Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001360859 | SCV001556812 | uncertain significance | Severe combined immunodeficiency due to DNA-PKcs deficiency | 2020-06-16 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals with PRKDC-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with tryptophan at codon 820 of the PRKDC protein (p.Arg820Trp). The arginine residue is moderately conserved and there is a moderate physicochemical difference between arginine and tryptophan. |
Ambry Genetics | RCV004036779 | SCV002738184 | uncertain significance | not specified | 2024-01-03 | criteria provided, single submitter | clinical testing | The c.2458C>T (p.R820W) alteration is located in exon 22 (coding exon 22) of the PRKDC gene. This alteration results from a C to T substitution at nucleotide position 2458, causing the arginine (R) at amino acid position 820 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |